STOCK TITAN

Lyntris (LYNX) president sells 238K IPO shares at $16.45

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Lyntris Inc. (LYNX) reported that director and President Matthew Alty sold 238,583 shares of common stock on 2026-08-20 in a sale classified as a selling stockholder transaction in the company’s initial public offering at $16.45 per share, which reflects the IPO price less underwriting discounts and commissions. After this sale, Alty directly holds 1,789,377 shares of common stock, and additional shares are held indirectly through irrevocable trusts over which he has voting and dispositive control.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Alty Matthew
Role President
Sold 238,583 shs ($3.92M)
Type Security Shares Price Value
Sale Common Stock F1, F2 238,583 $16.45 $3.92M
holding Common Stock F3 -- -- --
holding Common Stock F4 -- -- --
holding Common Stock F5 -- -- --
Holdings After Transaction: Common Stock — 1,789,377 shares (Direct); Common Stock — 357,870 shares (Indirect, See footnote)
Footnotes (5)
  1. F1. Represents shares sold by the Reporting Person as a selling stockholder in the Issuer's initial public offering.
  2. F2. Represents the IPO price, less underwriting discounts and commissions.
  3. F3. Shares are directly held by an irrevocable trust, over which Matthew Alty has voting and dispositive control.
  4. F4. Shares are directly held by an irrevocable trust, over which Matthew Alty has voting and dispositive control.
  5. F5. Shares are directly held by an irrevocable trust, over which Matthew Alty has voting and dispositive control.
Shares sold 238,583 shares of Common Stock Sale by Matthew Alty on 2026-08-20 as a selling stockholder in the IPO
Sale price $16.45 per share Represents the IPO price, less underwriting discounts and commissions
Direct holdings after transaction 1,789,377 shares of Common Stock Directly held by Matthew Alty following the 2026-08-20 sale
initial public offering financial
"shares sold by the Reporting Person as a selling stockholder in the Issuer's initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
selling stockholder financial
"shares sold by the Reporting Person as a selling stockholder in the Issuer's initial public offering"
A selling stockholder is an individual or entity that owns shares of a company's stock and chooses to sell some or all of those shares to others. This often occurs when the owner wants to cash in on their investment or reduce their stake. For investors, understanding who the selling stockholder is can provide insights into potential changes in the company's ownership or market activity.
irrevocable trust financial
"Shares are directly held by an irrevocable trust, over which Matthew Alty has voting"
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

FAQ

What insider transaction did Lyntris Inc. (LYNX) disclose for Matthew Alty?

Lyntris Inc. disclosed that Matthew Alty, its President and director, sold 238,583 shares of common stock on 2026-08-20 as a selling stockholder in the company’s initial public offering.

At what price were Matthew Alty’s LYNX shares sold?

The 238,583 shares of Lyntris Inc. common stock sold by Matthew Alty were transacted at $16.45 per share, which the filing states represents the IPO price, less underwriting discounts and commissions.

How many LYNX shares does Matthew Alty hold after this transaction?

Following the reported sale, Matthew Alty directly holds 1,789,377 shares of Lyntris Inc. common stock. The filing also notes additional indirect holdings in irrevocable trusts over which he has voting and dispositive control.

Was Matthew Alty’s LYNX share sale under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote indicating that the 238,583-share sale was made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.

How are Matthew Alty’s indirect LYNX holdings structured?

The filing states that certain Lyntris Inc. shares are held by irrevocable trusts, and that Matthew Alty has voting and dispositive control over these trust-held shares, which are therefore reported as indirect ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Alty Matthew

(Last)(First)(Middle)
C/O LYNTRIS INC.
3130 FAIRVIEW PARK DRIVE, SUITE 230

(Street)
FALLS CHURCH VIRGINIA 22042

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Lyntris Inc. [ LYNX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/20/2026S238,583(1)D$16.45(2)1,789,377D
Common Stock119,290ISee footnote(3)
Common Stock119,290ISee footnote(4)
Common Stock119,290ISee footnote(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares sold by the Reporting Person as a selling stockholder in the Issuer's initial public offering.
2. Represents the IPO price, less underwriting discounts and commissions.
3. Shares are directly held by an irrevocable trust, over which Matthew Alty has voting and dispositive control.
4. Shares are directly held by an irrevocable trust, over which Matthew Alty has voting and dispositive control.
5. Shares are directly held by an irrevocable trust, over which Matthew Alty has voting and dispositive control.
/s/ Tim Paulin, Attorney-in-Fact08/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)